Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Stock Price, Quote & AI Analysis

Live TEVA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Teva Pharmaceutical Industries Limited American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

TEVA
Teva Pharmaceutical Industries Limited American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
34.450000
High
35.420000
Low
34.145000
Volume
11,671,290
VWAP
-
Market Cap
$39,099,388,008.96
52W Range
$12.47 - $35.42
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Teva Pharmaceutical Industries Limited American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Teva Pharmaceutical Industries Limited American Depositary Shares Overview

Company information

Company Overview

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Company Details
Market Cap
$40.24B
Shares Outstanding
1,146,840,000
Weighted Shares Outstanding
1,147,282,512
CEO
Richard Francis
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Employees
35,686
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Teva Pharmaceutical Industries Limited American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...